Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
lapatinib + capecitabine
DRUG
2 trials
Sponsors
Novartis
, UNICANCER
Conditions
70 Years Old Patients and Over
After One Line of Chemotherapy With Trastuzumab
Metastatic Breast Cancer
Neoplasms, Breast
Phase 2
Evaluating Lapatinib + Capecitabine in Patients Aged 70 and Over With HER2 Metastatic Breast Cancer.
Completed
NCT01262469
UNICANCER
70 Years Old Patients and Over, After One Line of Chemotherapy With Trastuzumab, Metastatic Breast Cancer
Start: 2009-12-31
End: 2013-11-30
Updated: 2014-12-16
Unknown Phase
EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer
NCT00338247
Novartis
Neoplasms, Breast
Start: 2006-07-31
End: 2015-03-31
Updated: 2016-04-06
Related Papers
Clinical outcomes of HER2-positive metastatic breast cancer patients with brain metastasis treated with lapatinib and capecitabine: an open-label expanded access study in Korea.
2012-07-28
17 citations